Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RA0S2JEO7jRxcePUbpUK2PN_IhQvKG9hSWyCRjW4OAgt4#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "kyprolis is a proteasome inhibitor that is indicated in combination with dexamethasone or with lenalidomide plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy 1 14 as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy 1 14 kyprolis is indicated in combination with dexamethasone or with lenalidomide plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy kyprolis is indicated as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy" assertion.
- association subject drugbank:DB08889 assertion.
- association predicate treats assertion.
- association object DOID_9538 assertion.
- association relation TreatmentIndication assertion.
- DOID_9538 category Disease assertion.
- drugbank:DB08889 category Drug assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association provided_by NeuroDKG assertion.